| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.28B | +4.6% |
| Cost of Revenue | $2.77B | +4.8% |
| Gross Profit | $2.52B | +4.4% |
| R&D Expense | $447.3M | +7.8% |
| SG&A Expense | $425.0M | +18.7% |
| Operating Income | $1.14B | -8.0% |
| Interest Expense | $312.2M | +51.8% |
| Pre-tax Income | $876.1M | -15.5% |
| Income Tax | $227.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $440.1M | -22.0% |
| Accounts Receivable | $778.6M | +9.1% |
| Current Assets | $2.42B | -43.0% |
| Total Assets | $16.65B | -3.9% |
| Current Liabilities | $2.19B | -43.1% |
| Long-term Debt | $7.02B | +19.0% |
| Total Liabilities | $10.55B | -5.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.13B | -20.6% |
| Capital Expenditures | $63.4M | +23.6% |
| Investing Cash Flow | -$1.76B | -1086.0% |
| Financing Cash Flow | -$1.18B | -312.8% |
| Free Cash Flow | $1.07B | -22.3% |
| -3.9% |
| Net Income | $650.2M | -18.7% |
| EPS (Basic) | $2.56 | -18.2% |
| EPS (Diluted) | $2.48 | -17.1% |
| Stockholders' Equity |
| $6.04B |
| -2.0% |